AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST12, 2003
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(MARK ONE)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2003
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
FOR THE TRANSITION PERIOD FROM ___________________ TO _____________
COMMISSION FILE NUMBER 0-14669
THE ARISTOTLE CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
|
DELAWARE |
06-1165854 |
|
(STATE OR OTHER JURISDICTION OF |
(I.R.S. EMPLOYER |
|
INCORPORATION OR ORGANIZATION) |
IDENTIFICATION NO.) |
96 CUMMINGS POINT ROAD, STAMFORD, CONNECTICUT
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
06902
(ZIP CODE)
(203) 358-8000
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]
Indicate by check mark whether registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).
Yes [] No [X]
As of August 1, 2003, 17,031,687 shares of Common Stock, 1,046,716 shares of Series I Preferred Stock and 10,984,971 shares of Series J Preferred Stock were outstanding.
THE ARISTOTLE CORPORATION
INDEX OF INFORMATION CONTAINED IN FORM 10-Q FOR THE
QUARTER ENDED JUNE 30, 2003
|
PART I - FINANCIAL INFORMATION |
||||
|
Item 1. |
Financial Statements |
|||
|
Condensed Consolidated Balance Sheets at June 30, 2003 (unaudited) |
||||
|
and December 31, 2002 |
1 |
|||
|
Condensed Consolidated Statements of Earnings for the Three and Six |
||||
|
Months ended June 30, 2003 and 2002 (unaudited) |
2 |
|||
|
Condensed Consolidated Statements of Cash Flows for the Six Months |
||||
|
ended June 30, 2003 and 2002 (unaudited) |
3 |
|||
|
Notes to Condensed Consolidated Financial Statements (unaudited) |
4 |
|||
|
Item 2. |
Management's Discussion and Analysis of Financial Condition and Results of |
|||
|
Operations |
10 |
|||
|
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk |
15 |
||
|
Item 4. |
Controls and Procedures |
16 |
||
|
PART II - OTHER INFORMATION |
||||
|
Item 4. |
Submission of Matters to a Vote of Security Holders |
17 |
||
|
Item 6. |
Exhibits and Reports on Form 8-K |
18 |
||
PART I
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
|
Assets |
June 30, 2003 |
December 31, 2002 |
|||||
|
(unaudited) |
|||||||
|
Current assets: |
|||||||
|
Cash and cash equivalents |
$ |
8,850 |
11,299 |
||||
|
Accounts receivable, net |
19,152 |
12,452 |
|||||
|
Inventories |
34,705 |
27,941 |
|||||
|
Prepaid expenses and other |
6,102 |
7,766 |
|||||
|
Deferred income taxes |
7,251 |
7,251 |
|||||
|
Total current assets |
76,060 |
66,709 |
|||||
|
Property, plant and equipment, net |
17,126 |
9,153 |
|||||
|
Goodwill |
10,908 |
7,008 |
|||||
|
Deferred income taxes |
19,315 |
21,761 |
|||||
|
Other assets |
333 |
430 |
|||||
|
Total assets |
$ |
123,742 |
105,061 |
||||
|
Liabilities and Stockholders' Equity |
|||||||
|
Current liabilities: |
|||||||
|
Current installments of long-term debt |
$ |
10,560 |
9,108 |
||||
|
Trade accounts payable |
12,216 |
5,522 |
|||||
|
Accrued expenses |
3,798 |
3,979 |
|||||
|
Accrued dividends payable |
2,150 |
2,150 |
|||||
|
Income taxes |
690 |
1,005 |
|||||
|
Total current liabilities |
29,414 |
21,764 |
|||||
|
Long-term debt, less current installments |
37,463 |
27,579 |
|||||
|
Stockholders' equity: |
|||||||
|
Preferred stock, Series I, convertible, voting, 11% cumulative, $6.00 stated |
|||||||
|
value; $.01 par value; 2,400,000 shares authorized, 1,046,716 shares |
|||||||
|
issued and outstanding |
6,280 |
6,280 |
|||||
|
Preferred stock, Series J, non-voting, 12% cumulative, $6.00 stated value; |
|||||||
|
$.01 par value; 11,200,000 shares authorized, 10,984,971 shares |
|||||||
|
issued and outstanding |
65,760 |
65,760 |
|||||
|
Common stock, $.01 par value; 20,000,000 shares authorized, 17,031,687 |
|||||||
|
shares issued and outstanding |
170 |
170 |
|||||
|
Additional paid-in capital |
512 |
251 |
|||||
|
Accumulated deficit |
(15,626) |
(16,624) |
|||||
|
Accumulated other comprehensive loss |
(231) |
(119) |
|||||
|
Total stockholders' equity |
56,865 |
55,718 |
|||||
|
Total liabilities and stockholders' equity |
$ |
123,742 |
105,061 |
||||
The accompanying notes are an integral part of these condensed consolidated financial statements
.1
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(in thousands, except share and per share data)
(Unaudited)
|
Three Months Ended |
Six Months Ended |
|||||||||||||
|
June 30, |
June 30, |
|||||||||||||
|
2003 |
2002 |
2003 |
2002 |
|||||||||||
|
Net sales |
$ |
42,961 |
43,322 |
78,402 |
77,851 |
|||||||||
|
Cost of sales |
26,734 |
27,987 |
48,937 |
50,264 |
||||||||||
|
Gross profit |
16,227 |
15,335 |
29,465 |
27,587 |
||||||||||
|
Selling and administrative expense |
10,332 |
10,053 |
20,118 |
19,518 |
||||||||||
|
Earnings from operations |
5,895 |
5,282 |
9,347 |
8,069 |
||||||||||
|
Other expense (income): |
||||||||||||||
|
Interest expense |
371 |
508 |
679 |
966 |
||||||||||
|
Other, net |
(6) |
8 |
(55) |
(17) |
||||||||||
|
365 |
516 |
624 |
949 |
|||||||||||
|
Earnings before income taxes and extraordinary |
||||||||||||||
|
gain |
5,530 |
4,766 |
8,723 |
7,120 |
||||||||||
|
Income taxes: |
||||||||||||||
|
Current |
770 |
1,610 |
979 |
2,512 |
||||||||||
|
Deferred |
1,414 |
330 |
2,446 |
330 |
||||||||||
|
2,184 |
1,940 |
3,425 |
2,842 |
|||||||||||
|
Earnings before extraordinary gain |
3,346 |
2,826 |
5,298 |
4,278 |
||||||||||
|
Extraordinary gain |
- |
20,237 |
- |
20,237 |
||||||||||
|
Net earnings |
3,346 |
23,063 |
5,298 |
24,515 |
||||||||||
|
Preferred dividends |
2,150 |
306 |
4,300 |
306 |
||||||||||
|
Net earnings applicable to common shareholders |
$ |
1,196 |
22,757 |
998 |
24,209 |
|||||||||
|
Basic earnings per common share: |
||||||||||||||
|
Earnings before extraordinary gain, applicable to |
||||||||||||||
|
common shareholders |
$ |
0.07 |
0.16 |
0.06 |
0.26 |
|||||||||
|
Extraordinary gain |
- |
1.33 |
- |
1.34 |
||||||||||
|
Net earnings applicable to common shareholders |
$ |
0.07 |
1.49 |
0.06 |
1.60 |
|||||||||
|
Diluted earnings per common share: |
||||||||||||||
|
Earnings before extraordinary gain, applicable to |
||||||||||||||
|
common shareholders |
$ |
0.07 |
0.16 |
0.06 |
0.26 |
|||||||||
|
Extraordinary gain |
- |
1.31 |
- |
1.31 |
||||||||||
|
Net earnings applicable to common shareholders |
$ |
0.07 |
1.47 |
0.06 |
1.57 |
|||||||||
|
Weighted average common shares outstanding: |
||||||||||||||
|
Basic |
17,031,687 |
15,290,241 |
17,031,687 |
15,145,922 |
||||||||||
|
Diluted |
17,120,547 |
15,518,106 |
17,144,852 |
15,373,787 |
||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
|
Six Months Ended |
||||||||||
|
June 30, |
||||||||||
|
2003 |
2002 |
|||||||||
|
Cash flows from operating activities: |
||||||||||
|
Net earnings |
$ |
5,298 |
24,515 |
|||||||
|
Adjustments to reconcile net earnings to net cash |
||||||||||
|
provided by operating activities: |
||||||||||
|
Extraordinary gain |
- |
(20,237) |
||||||||
|
Depreciation |
858 |
797 |
||||||||
|
Stock option compensation |
261 |
17 |
||||||||
|
Loss on sale of property, plant and equipment |
18 |
10 |
||||||||
|
Deferred income taxes |
2,446 |
330 |
||||||||
|
Change in assets and liabilities, net of effects of acquired business: |
||||||||||
|
Accounts receivable |
(6,254) |
(4,835) |
||||||||
|
Inventories |
(5,811) |
(7,898) |
||||||||
|
Prepaid expenses and other |
1,779 |
642 |
||||||||
|
Other assets |
97 |
(36) |
||||||||
|
Trade accounts payable |
6,529 |
7,927 |
||||||||
|
Accrued expenses and other liabilities |
(892) |
1,260 |
||||||||
|
Net cash provided by operating activities |
4,329 |
2,492 |
||||||||
|
Cash flows from investing activities: |
||||||||||
|
Purchases of property, plant and equipment |
(3,311) |
(764) |
||||||||
|
Proceeds from the sale of property, plant and equipment |
8 |
- |
||||||||
|
Cash acquired in merger with Nasco |
- |
3,272 |
||||||||
|
Cash paid for acquisitions, net of cash acquired |
(3,449) |
- |
||||||||
|
Net cash provided by (used in) investing activities |
(6,752) |
2,508 |
||||||||
|
Cash flows from financing activities: |
||||||||||
|
Proceeds from issuance of long-term debt |
4,410 |
- |
||||||||
|
Principal payments on long-term debt |
(136) |
(377) |
||||||||
|
Preferred dividends paid |
(4,300) |
- |
||||||||
|
Net cash used in financing activities |
(26) |
(377) |
||||||||
|
Net increase (decrease) in cash and cash equivalents |
(2,449) |
4,623 |
||||||||
|
Cash and cash equivalents at beginning of period |
11,299 |
4,465 |
||||||||
|
Cash and cash equivalents at end of period |
$ |
8,850 |
9,088 |
|||||||
|
Supplemental cash flow information |
||||||||||
|
Cash paid during the period for: |
||||||||||
|
Interest |
$ |
466 |
943 |
|||||||
|
Income taxes |
$ |
1,294 |
400 |
|||||||
|
Non-cash investing and financing activities: |
||||||||||
|
Notes payable and capital lease executed in connection with acquisitions |
$ |
7,062 |
- |
|||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2003
(Unaudited)
(Unaudited)
The Aristotle Corporation ("Aristotle") and its subsidiaries (together with Aristotle, the "Company"), founded in 1986, and headquartered in Stamford, CT, is a leading manufacturer and global distributor of educational, health and agricultural products.
Prior to June 17, 2002, Aristotle was a holding company which, through its subsidiaries, Simulaids, Inc. ("Simulaids") and Safe Passage International, Inc. ("Safe Passage"), conducted business in two segments, the medical education and training products market and the computer-based training market. On June 17, 2002, Aristotle merged (the "Merger") with Nasco International, Inc. ("Nasco"), an indirect subsidiary of Geneve Corporation ("Geneve"), a privately-held diversified financial services company. Pursuant to the Merger, the separate corporate existence of Nasco ceased and Aristotle was the surviving entity. Immediately following the Merger, Aristotle's business was comprised of the operations of the Nasco group of companies, Simulaids and Safe Passage. Due to the relative sizes of the parties and conditions to the Merger, the transaction was accounted for as a reverse acquisition using the purchase method of accounting under accounting principles generally accepted in the United State s of America. Accordingly, for accounting and reporting purposes, Nasco is deemed to be the acquiring company, and financial information reported for periods prior to the Merger is that of Nasco. In applying purchase accounting to the Merger, the assets and liabilities of Aristotle were adjusted to their fair market values at June 17, 2002. This included recognition of a significant deferred tax asset of approximately $30.7 million, which was principally attributable to Aristotle's Federal net operating tax loss carryforwards. As a result of such recognition, Aristotle's pre-merger goodwill and long-term assets of $8.3 million were reduced to zero and negative goodwill of $20.2 million was recognized as an extraordinary gain at the acquisition date.
Nasco, founded in 1941, is a leading manufacturer and global distributor of educational, health and agricultural products. A selection of over 80,000 items is offered, primarily through catalogs carrying the brand of Nasco, as well as those bearing the brands of Triarco, Summit Learning, Hubbard Scientific, Scott Resources, Spectrum Educational Supplies, Haan Crafts and To-Sew. Products include educational materials and supplies for substantially all K-12 curricula, molded plastics, biological materials, and items for the agricultural, senior care and food industries. Nasco, together with Simulaids, also offers simulation kits and manikins used for training in cardiopulmonary resuscitation, and the fire and emergency rescue and patient care fields. The Company markets proprietary product lines throughout all of its catalogs that provide exclusive distribution rights. The proprietary product lines are developed internally through the Company's research and development efforts and acq uired externally through licensing rights from third parties.
On December 31, 2002, Aristotle sold its 80% ownership interest in Safe Passage in exchange for certain contingent payments. The contingent payments are payable through 2008 and are based upon the financial performance of Safe Passage. The business and activities of Safe Passage were not material to the operations of the Company.
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and do not include all of the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2003 are not necessarily indicative of results that may be expected for any other interim period or for the year ended December 31, 2003. For further information, refer to the consolidated financial statements and notes included in the Company's Proxy Statement-Prospectus dated May 15, 2002, Annual Report on Form 10-K for the year ended December 31, 2002 and Quarterly Report on Form 10-Q for the quarter period ended March 31, 2003.
4
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2003
(Unaudited)
(Unaudited)
On May 31, 2003, Aristotle purchased 100% of the outstanding capital stock of Haan Crafts Corporation ("Haan"). Haan is a manufacturer and catalog distributor of sewing kits used in middle school and junior high school family and consumer science classrooms. The acquisition has complemented the Company's current product lines. The results of Haan's operations have been included in the consolidated financial statements since the date of such acquisition. The aggregate purchase price, net of cash acquired, was $5.3 million, including $3.5 million of cash and $1.8 million in seller financing. The purchase price allocation resulted in goodwill of $3.9 million attributable to the educational segment. In connection with the acquisition of Haan, Aristotle entered into a $1.2 million capital lease with the seller on a building facility.
The following unaudited pro forma results of operations for three and six months ended June 30, 2003 and 2002 (in thousands) have been prepared as if the Haan acquisition had occurred on January 1, 2002:
|
Three Months Ended |
Six Months Ended |
|||||||||
|
June 30, |
June 30, |
|||||||||
|
|
|
2003 |
2002 |
2003 |
2002 |
|||||
|
Net sales |
$ |
44,025 |
44,468 |
81,248 |
80,804 |
|||||
|
Earnings before extraordinary gain |
3,486 |
2,872 |
5,896 |
4,672 |
||||||
|
Net earnings |
$ |
3,486 |
23,109 |
5,896 |
24,909 |
|||||
|
Preferred dividends |
2,150 |
306 |
4,300 |
306 |
||||||
|
Net earnings applicable to |
||||||||||
|
common shareholders |
$ |
1,336 |
22,803 |
1,596 |
24,603 |
|||||
|
Basic earnings per common share: |
||||||||||
|
Earnings before extraordinary gain, |
||||||||||
|
applicable to common shareholders |
$ |
0.08 |
0.17 |
0.09 |
0.29 |
|||||
|
Extraordinary gain |
- |
1.33 |
- |
1.34 |
||||||
|
Net earnings applicable to common |
||||||||||
|
shareholders |
$ |
0.08 |
1.50 |
0.09 |
1.63 |
|||||
|
Diluted earnings per common share: |
||||||||||
|
Earnings before extraordinary gain, |
||||||||||
|
applicable to common shareholders |
$ |
0.08 |
0.17 |
0.09 |
0.28 |
|||||
|
Extraordinary gain |
- |
1.31 |
- |
1.31 |
||||||
|
Net earnings applicable to common |
||||||||||
|
shareholders |
$ |
0.08 |
1.48 |
0.09 |
1.59 |
|||||
The pro forma financial information above is provided for comparative purposes only and should not be construed to be indicative of the Company's results of operations had the acquisition been consummated on January 1, 2002, and is not intended to project the Company's results of operations for any future period.
On May 31, 2003, Aristotle acquired 100% of the outstanding ownership interests in NHI, LLC ("NHI") from Nasco Holdings, Inc. ("Holdings"), a subsidiary of Geneve. This transaction was consummated in satisfaction of a contractual obligation entered into in connection with the Merger. The sole purpose of NHI is the ownership and management of a building facility, which had been leased to Aristotle. In connection with the purchase of NHI, Aristotle paid to Holdings an amount equal to the book value of NHI and assumed the mortgage related to the property held by NHI.
5
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2003
(Unaudited)
(Unaudited)
In June 2001, the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") No. 143, Accounting for Asset Retirement Obligations ("SFAS 143"). SFAS 143 requires the Company to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. The Company also records a corresponding asset that is depreciated over the life of the asset. Subsequent to the initial measurement of the asset retirement obligation, the obligation will be adjusted at the end of each period to reflect the passage of time and changes in the estimated future cash flows underlying the obligation. The Company adopted SFAS 143 on January 1, 2003. The adoption of SFAS 143 did not have a material effect on the Compan y's financial statements for the three and six months ended June 30, 2003.
In June 2002, the FASB issued SFAS No.146, Accounting for Costs Associated with Exit or Disposal Activities ("SFAS 146"), which addresses financial accounting and reporting for costs associated with exit or disposal activities and supersedes Emerging Issues Task Force ("EITF") Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring). SFAS 146 requires companies to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of a commitment to an exit or disposal plan. In addition, SFAS 146 establishes that fair value is the objective for initial measurement of the liability. SFAS 146 is effective for exit or disposal activities initiated after December 31, 2002. The adoption of SFAS 146 did not have a material effect on the Company's financial statements for the three and six months ende d June 30, 2003.
In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51 ("Interpretation 46"). Interpretation 46 addresses the consolidation by business enterprises of variable interest entities. Interpretation 46 applies immediately to variable interests in variable interest entities created after January 31, 2003, and to variable interests in variable interest entities obtained after January 31, 2003. Interpretation 46 requires certain disclosures in financial statements issued after January 31, 2003 if it is reasonably possible that the Company will consolidate or disclose information about variable interest entities when Interpretation 46 becomes effective. The adoption of Interpretation 46 did not have a material effect on the Company's financial statements for the three and six months ended June 30, 2003.
In November 2002, the EITF issued Issue No. 02-16, Accounting for Consideration Received from a Vendor by a Customer (Including a Reseller of the Vendor's Products) ("EITF 02-16"), effective for fiscal periods beginning after December 15, 2002. EITF Issue No. 02-16 requires cash consideration received from a vendor be recognized in the customer's financial statements as a reduction to cost of goods sold, unless certain limited conditions are met. If these specific requirements related to individual vendors are met, the consideration is accounted for as a reduction in the related expense category, such as advertising or selling and administrative expense. The adoption of EITF 02-16 did not have a material effect on the Company's financial statements for the three and six months ended June 30, 2003.
In April 2003, the FASB issued SFAS No. 149, Amendment of Statement 133 on Derivative Instruments and Hedging Activities ("SFAS 149"). SFAS 149 amends and clarifies financial accounting and reporting for derivative instruments, including certain derivative instruments embedded in other contracts and for hedging activities under SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. SFAS No. 149 is effective for contracts entered into or modified after June 30, 2003 and for hedging relationships designated after June 30, 2003. The adoption of SFAS 149 is not expected to have a material effect on the Company's financial statements.
6
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2003
(Unaudited)
(Unaudited)
In May 2003, the FASB issued SFAS No. 150, Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity ("SFAS 150"). SFAS 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. It requires an issuer to classify a financial instrument that is within its scope as a liability (or an asset in some circumstances). An issuer previously classified many of those instruments as equity. The Statement is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective for interim periods beginning after June 15, 2003.
The adoption of SFAS 150 is not expected to have a material effect on the Company's financial statements.The Company has one stock plan available to employees, directors and consultants and one plan available to employees and directors. In 2002, the Company adopted a change in accounting principle to adopt the fair value-based recognition and measurement provisions of SFAS No.123, Accounting for Stock-Based Compensation ("SFAS 123"), which requires the fair value of stock options granted to employees to be measured at the date of grant and recognized as an expense over the service period, which is usually the vesting period of the grant. Under SFAS 123, the Company recognizes the fair value of stock options granted on or after January 1, 2002 as an expense on its income statement over the vesting period of the grant. Previously, the Company accounted for fixed plan stock option grants using the intrinsic value-based method, and recognized expense only when the grant date fair value of the underlying stock exceeded the exercise price under the award. No s tock options were issued during the three months ended June 30, 2003. The total fair value of the options issued during the six months ended June 30, 2003 was $0.4 million. The total fair value of options granted under the 2002 Employee, Director and Consultant Stock Plan is recognized as non-cash compensation expense over the three year vesting period for such options. The Company recorded compensation expense related to issued stock options of approximately $0.2 million for the three months ended June 30, 2003 compared to less than $0.1 million for the three months ended June 30, 2002. The Company recorded compensation expense related to issued stock options of approximately $0.3 million for the six months ended June 30, 2003 compared to less than $0.1 million for the six months ended June 30, 2002. The expected annual impact on earnings before income taxes of the options granted to date is a reduction of approximately $0.5 million.
Comprehensive earnings for the three and six months ended June 30 is as follows (in thousands):
|
Three Months Ended |
Six Months Ended |
||||||||
|
June 30, |
June 30, |
||||||||
|
|
|
2003 |
2002 |
2003 |
2002 |
||||
|
Net earnings |
$ |
3,346 |
23,063 |
5,298 |
24,515 |
||||
|
Foreign currency translation |
|||||||||
|
adjustment |
(90) |
(17) |
(112) |
5 |
|||||
|
Net unrealized investment gain |
|
- |
14 |
- |
14 |
||||
|
Comprehensive earnings |
$ |
3,256 |
23,060 |
5,186 |
24,534 |
||||
7
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2003
(Unaudited)
Basic earnings per share is calculated by dividing net earnings applicable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share is calculated by dividing net earnings applicable to common shareholders by the weighted average number of common shares outstanding during the period and including each share that would have been outstanding assuming the issuance of common shares for all dilutive potential common shares outstanding during the period.
Shares of Common Stock available for issue upon conversion of the 1,046,716 shares of Series I Preferred Stock were not dilutive and, therefore, have not been included in the computations of diluted earnings per common share amounts for the three and six months ended June 30, 2003 and 2002.
The Company's business activities are organized into two business segments, educational and commercial. The educational segment relates to instructional teaching aids and materials, which are distributed to educational institutions principally in North America, for kindergarten through grade 12 classes, and for nursing school and emergency medical instructors. Products in the educational segment are marketed primarily through catalogs. The growth potential of the educational segment is directly related to school enrollments and the strength of government funding of education. The commercial segment relates to agricultural products, sterile sampling containers and systems, materials for nursing home activities and novelty and gift products. Products in the commercial segment are marketed through catalogs nationwide, and through a worldwide dealer network covering more than 60 countries. Market growth in the commercial segment is principally impacted by the general econom ic conditions of world agriculture, the increasing size of the aged population, as well as increasing global awareness of food and water quality standards. The Company evaluates the performance of these segments based on segment net sales and gross profit.
The following table presents segment profitability information for the three and six months ended June 30 (in thousands):
|
Three Months Ended |
Six Months Ended |
|||||||||
|
June 30, |
June 30, |
|||||||||
|
|
|
2003 |
2002 |
2003 |
2002 |
|||||
|
Net sales: |
|
|
|
|
||||||
|
|
Educational |
$ |
36,727 |
35,974 |
65,727 |
63,235 |
||||
|
|
Commercial |
|
7,391 |
|||||||